New technologies for the surgical management of symptomatic benign prostatic enlargement: Tolerability and morbidity of high energy transurethral microwave thermotherapy

Current Opinion in Urology

Volumn 10, Issue 1, 2000, Pages 15-17

  Eliasson, Tomas ^a   Wagrell, Lennart ^b  

^a UMEÅ UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANALGESIC AGENT; ANTIBIOTIC AGENT; DIAZEPAM; LIDOCAINE; NONSTEROID ANTIINFLAMMATORY AGENT; PETHIDINE;

ADULT; AGED; AMBULATORY SURGERY; ANALGESIA; ANESTHESIA; ANXIETY; EPIDIDYMITIS; HEMATURIA; HUMAN; MALE; MEDICAL TECHNOLOGY; MICTURITION DISORDER; MORBIDITY; NOCICEPTION; PAIN; PATIENT COMPLIANCE; PERIOPERATIVE PERIOD; PREOPERATIVE CARE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RETROGRADE EJACULATION; REVIEW; SEXUAL FUNCTION; SURGICAL TECHNIQUE; TRANSURETHRAL MICROWAVE THERMOTHERAPY; TREATMENT OUTCOME; URETHRA STRICTURE; URINARY TRACT INFECTION; URINE CATHETER; URINE RETENTION;

HUMANS; HYPERTHERMIA, INDUCED; MALE; MICROWAVES; MORBIDITY; PROSTATIC HYPERPLASIA; URETHRA;

EID: 0033984607     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042307-200001000-00004     Document Type: Review

References (17)

1. 1 de la Rosette JJMCH, D'Ancona FCH, Debruyne FMJ. Current status of thermotherapy of the prostate. J Urol 1997; 157:430-438.
2. 2 Hallin A, Berlin T. Transurethral microwave thermotherapy for benign prostatic hyperplasia: clinical outcome after 4 years. J Urol 1998; 159:459-464. This is a stringent Swedish study of long-term follow up of low-energy thermotherapy, in which the outcome of all the included patients are properly reported.
3. 3 de Wildt MJAM, Tubaro A, Höffner K, Carter SStC, de la Rosette JJMCH, Devonec M. Responders and non-responders to transurethral microwave thermotherapy: a multicenter retrospective analysis. J Urol 1995; 154:1775-1778.
4. 4 Huskisson EC. Measurement of pain. Lancet 1974; 9:1127-1131.
5. 5 Scott J, Huskisson EC. Graphic representation of pain. Pain 1976; 2:175-184.
6. 6 Djavan B, Shariat S, Schäfer B, Marberger M. Tolerability of high energy transurethral microwave thermotherapy with topical anesthesia: results of a prospective, randomized, single-blinded clinical trial. J Urol 1999; 160:772-776. To date, this is the only published study that focused on tolerability.
7. 7 Eliasson T, Damber J-E. Temperature-controlled high-energy transurethral microwave thermotherapy for benign prostatic hyperplasia using a heatshock strategy. J Urol 1998; 160:777-782. This is the first published clinical study to address a new treatment protocol, with a temperature-controlled quick increase in high-energy thermotherapy.
8. 8 Eliasson T, Abramsson L, Damber J-E. Importance of thermal dose and antenna localisation in transurethral microwave thermotherapy for benign prostatic hyperplasia. J Endourol 1998; 12:581-589.
9. 9 Larson TR, Blute ML, Bruskewitz RC, Mayer RD, Ugarte RR, Utz WJ. A high-efficiency microwave thermoabalation system for the treatment of benign prostatic hyperplasia: results of a randomized, sham-controlled, prospective, double-blind, multicenter clinical trial. Urology 1998; 51:731-742.
10. 10 D'Ancona FCH, Francisca EAE, Debruyne FMJ, de la Rosette JJMCH. High energy transurethral microwave thermotherapy in the treatment of patients with lower urinary tract symptoms. J Endourol 1997; 11:285-289.
11. 11 Djavan B, Fakhari M, Shariat S, Ghawidel K, Marberger M. A novel intraurethral prostatic bridge catheter for prevention of temporary prostatic obstruction following high energy transurethral microwave thermotherapy in patients with benign prostatic hyperplasia. J Urol 1999; 161:144-151. This is another study from this productive group in Vienna in an attempt to reduce the post-TUMT morbidity of urinary retention with a new option of a prostatic bridge catheter.
12. 12 Djavan B, Shariat S, Fakhari M, Ghawidel K, Seitz C, Partin AW, et al. Neoadjuvant and adjuvant alpha-blockade improves early results of high-energy transurethral microwave thermotherapy for lower urinary tract symptoms of benign prostatic hyperplasia: a randomized, prospective clinical trial. Urology 1999; 53:251-259. This is an excellent study and is the first clinical trial aimed at identifying ways to reduce post-TUMT morbidity.
13. 13 Lau Ko, Li MK, Foo KT. Long-term follow-up of transurethral microwave thermotherapy. Urology 1998; 52:829-833.
14. 14 D'Ancona FCH, Francisca EAE, Witjes WPJ, Welling L, Debruyne FMJ, de la Rosette JJMCH. High energy transurethral thermotherapy (TUMT) versus transurethral resection of the prostate (TURP): results of a prospective randomized study with a 1 year follow-up. J Urol 1997; 158:120-125.
15. 15 Francisca EAE, D'Ancona FCH, Meuleman EJH, Debruyne FMJ, de la Rosette JJMCH. Sexual function following high energy microwave thermotherapy: results of a randomized controlled study comparing transurethral microwave thermotherapy to transurethral prostatic resection. J Urol 1999; 161:486-490. This study addresses an important issue in the field of microwave therapy.
16. 16 Djavan B, Roehrborn CG, Shariat S, Ghawidel K, Marberger M. Prospective randomized comparison of high energy transurethral microwave thermotherapy versus α-blocker treatment of patients with benign prostatic hyperplasia. J Urol 1999; 161:139-143.
17. 17 D'Ancona FCH, Francisca EAE, Witjes WPJ, Welling L, Debruyne FMJ, de la Rosette JJMCH. Transurethral resection of the prostate vs high-energy thermotherapy of the prostate in patients with benign prostatic hyperplasia: long-term results. Br J Urol 1998; 81:259-264. This is a randomized study reporting symptomatic and objective outcome at 2.4-year follow up.